Atherogenic Lipoprotein Phenotype and Low-Density Lipoproteins Size and Subclasses in Women with Polycystic Ovary Syndrome
Kaspar Berneis, Enrico Carmina(OHB (Italy)), Veronica Lazzaroni(University of Pisa), Manfredi Rizzo(University of Palermo), Franca Fruzzetti(University of Pisa)
Cited by 122
Related Papers
Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
|Fertility and Sterility|2011|2k
Polycystic ovary syndrome
|Nature Reviews Disease Primers|2016|1.9k
Complications of Diabetes 2017
|Journal of Diabetes Research|2018|644
American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part 1
|Endocrine Practice|2015|628
Polycystic Ovary Syndrome (PCOS): Arguably the Most Common Endocrinopathy Is Associated with Significant Morbidity in Women
|The Journal of Clinical Endocrinology & Metabolism|1999|508